Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01540994 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
A NA study, sponsored by Sharp HealthCare.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01540994: Completed NA study, sponsored by Sharp HealthCare.
NCT01540994 is a NA study that has completed, run by Sharp HealthCare. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01540994, a NA study, has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a short course (five radiation treatments) of very focused ("stereotactic") external beam radiation therapy for the treatment of early stage prostate cancer.
Interventions
- RADIATION Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-01 |
| Est. Completion | 2019-04-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01540994
The ClinicalTrials.gov registry entry for NCT01540994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT01540994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01540994 about?
NCT01540994 is a clinical study titled "Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer". The purpose of this study is to evaluate a short course (five radiation treatments) of very focused ("stereotactic") external beam radiation therapy for the treatment of early stage prostate cancer.
What is the current status of trial NCT01540994?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2011-01. Estimated completion is 2019-04-05.
What interventions are being tested in trial NCT01540994?
The interventions under investigation include: Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT01540994?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.